Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP26A1 | O43174 | 4/20 | 0.49 |
| ▸ | CTSA | P10619 | 13/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.42 |
| ▸ | PDE5A | O76074 | 1/20 | 0.42 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15635281 | 0.92 | APLNR (0.49) | CYP26A1CTSACYP3A4MMEAPLNR | |
| SCHEMBL15635936 | 0.91 | CTSA (0.47) | CYP26A1CTSA | |
| SCHEMBL15636487 | 0.90 | CTSA (0.46) | CYP26A1CTSACYP3A4MMEAPLNR | |
| SCHEMBL15636249 | 0.89 | CYP26A1 (0.53) | CYP26A1CTSA | |
| SCHEMBL15636745 | 0.89 | CYP26A1 (0.53) | CYP26A1CTSA | |
| SCHEMBL15637059 | 0.89 | CYP26A1 (0.53) | CYP26A1CTSACYP3A4MME | |
| SCHEMBL15636169 | 0.88 | CTSA (0.56) | CTSACYP3A4MME | |
| SCHEMBL15636851 | 0.88 | CTSA (0.50) | CYP26A1CTSACYP3A4MME | |
| SCHEMBL15636168 | 0.88 | CTSA (0.57) | CYP26A1CTSA | |
| SCHEMBL15636963 | 0.87 | CTSA (0.54) | CYP26A1CTSACYP3A4MMEAPLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |